Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice
Newsletter subscription
Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice
Languages
ENGLISH
English (US)
ASIAN
Монгол
日本語
Tiếng Việt
Bahasa Indonesia
中文 (简体, 中国大陆)
EUROPEAN
Русский
Español (España)
Français (France)
MIDDLE_EAST_AFRICA
العربية
Search results for "Obesity Treatment Injection"
Home
'10kg Weight Loss' Pani Bottle, Yo-Yo After Stopping Wegovy
Travel YouTuber Pani Bottle confessed to experiencing a yo-yo effect. Pani Bottle recently posted a photo taken during his travels on his social...
02/03/2026, 04:16 ET
“Half the Price of Mounjaro”: South Korea’s First Homegrown Obesity Drug Epe Enters the Market
The first domestically developed obesity medication is entering South Korea’s weight-loss market, long dominated by foreign pharmaceuticals such as...
11/09/2026, 01:01 ET
Hanmi’s ‘Epe’ Wins MFDS Approval, Becoming South Korea’s First Homegrown GLP-1 Obesity Drug
A domestically developed therapy has entered South Korea’s obesity treatment market, long dominated by imported...
10/16/2026, 22:37 ET
From Returned Candidate to Homegrown Breakthrough: Hanmi’s ‘Epe’ Prepares to Challenge Wegovy and Mounjaro
Efpeglenatide, a drug candidate whose development rights were once returned by a global pharmaceutical giant, is...
10/16/2026, 04:57 ET
JW Pharmaceutical Files for Phase 3 Trial of Biweekly Obesity Drug Bofanglutide
JW Pharmaceutical announced on Aug. 18 that it has submitted an Investigational New Drug application to South Korea’s...
08/22/2026, 20:13 ET
Losing Weight Fast on Wegovy or Mounjaro? How High-Protein Foods Prevent Rebound
Popular anti-obesity injections like Wegovy and Mounjaro reduce appetite and prolong feelings of fullness.
08/21/2026, 02:20 ET
Forget Wegovy and Mounjaro: How Hanmi’s 'EPPE' Is Redefining Obesity Care
Hanmi Pharmaceutical has officially named its in-development obesity treatment "EPPE.
08/03/2026, 09:55 ET
Lilly’s Retatrutide Cuts Weight by 22.6% in Phase 3 Trials, But Cardiovascular Protection Remains Unproven
Eli Lilly and Company’s next-generation obesity treatment, retatrutide, reduced body weight by up to 22.
07/27/2026, 05:31 ET
Novo Nordisk Secures EU Green Light for Oral Wegovy, Outpacing Eli Lilly in the Pill Market
The glucagon-like peptide-1 (GLP-1) obesity treatment market, long dominated by subcutaneous injections, is rapidly...
07/20/2026, 19:27 ET
Can Certain Foods Make Body Odor Worse? Unveiling the Unexpected Triggers of Personal Scent
In crowded, enclosed spaces during the summer—such as subway cars or elevators—the body odor of others often feels...
07/12/2026, 01:37 ET
1
2
Next